Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.25
+2.00 (9.88%)
At close: Apr 2, 2026
Market Cap18.02B +73.6%
Revenue (ttm)1.90B +39.1%
Net Income337.87M +217.0%
EPS0.51 +111.0%
Shares Out810.02M
PE Ratio43.95
Forward PE31.47
Dividend0.70 (3.14%)
Ex-Dividend DateNov 24, 2025
Volume7,407,595
Average Volume4,284,886
Open20.70
Previous Close20.25
Day's Range20.55 - 22.25
52-Week Range14.65 - 40.10
Betan/a
RSI56.87
Earnings DateApr 23, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd. [Read more]

Employees 20
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements